Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 20-05-2026
NAV ₹15.14(R) +0.1% ₹15.76(D) +0.1%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 18.43% -% -% -% -%
Direct 20.48% -% -% -% -%
Nifty Pharma TRI 16.62% 27.51% 13.03% 17.44% 9.17%
SIP (XIRR) Regular 20.28% -% -% -% -%
Direct 22.31% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr

NAV Date: 20-05-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 15.14
0.0200
0.1000%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 15.76
0.0200
0.1000%

Review Date: 20-05-2026


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 9.34 10.63
8.98
7.33 | 10.94 5 | 16 Good
3M Return % 10.57 10.65
10.31
6.66 | 12.33 9 | 16 Average
6M Return % 7.38 9.75
6.90
3.16 | 11.55 7 | 16 Good
1Y Return % 18.43 16.62
13.20
7.12 | 21.14 2 | 15 Very Good
1Y SIP Return % 20.28
17.85
10.83 | 26.46 4 | 15 Very Good
Return data last Updated On : May 20, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 9.50 10.63 9.09 7.47 | 11.09 5 | 16 Good
3M Return % 11.03 10.65 10.68 7.11 | 12.73 8 | 16 Good
6M Return % 8.30 9.75 7.62 3.89 | 12.18 7 | 16 Good
1Y Return % 20.48 16.62 14.73 8.86 | 22.56 2 | 15 Very Good
1Y SIP Return % 22.31 19.39 12.40 | 27.88 4 | 15 Very Good
Return data last Updated On : May 20, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
20-05-2026 15.143 15.758
19-05-2026 15.128 15.742
18-05-2026 15.025 15.633
15-05-2026 15.014 15.62
14-05-2026 14.996 15.6
13-05-2026 14.8 15.395
12-05-2026 14.766 15.36
11-05-2026 15.066 15.671
08-05-2026 14.926 15.523
07-05-2026 14.83 15.423
06-05-2026 14.78 15.37
05-05-2026 14.514 15.093
04-05-2026 14.494 15.071
30-04-2026 14.219 14.782
29-04-2026 14.219 14.782
28-04-2026 14.154 14.714
27-04-2026 14.231 14.793
24-04-2026 13.901 14.447
23-04-2026 14.032 14.584
22-04-2026 13.893 14.437
21-04-2026 13.845 14.387
20-04-2026 13.849 14.391

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.